NEXO is trading at $0.835264, with a 24-hour change of -0.08398%, so the latest daily move is nearly flat but slightly negative. The price is about 0.68% below the $0.841006 high and 2.80% above the $0.812492 low, placing it in the upper part of the reported daily range without confirming a sustained advance.

The short hourly averages are supportive: price is above the 8-hour SMA at $0.8278, the 13-hour SMA at $0.8306, and the 21-hour SMA at $0.8305. Their reported gaps of +0.90%, +0.57%, and +0.58% point to modest near-term strength, rather than a strong breakout signal.

That positive reading conflicts with the longer hourly averages, as price is below the 55-hour SMA at $0.8372 and the 144-hour SMA at $0.8462. The gaps of -0.23% and -1.29% show that the short-term improvement has not yet carried price above these slower reference levels.

Momentum readings are mixed but not extreme. The 1-hour RSI of 55 is mildly positive, while the 7-day RSI of 48 is close to neutral, so neither reading provides strong confirmation of a directional move.

The performance figures lean bearish across the supplied periods: NEXO is down 1.3152% over seven days, 3.1593% over 14 days, and 0.4413% over 30 days. The 30-day decline is small, but all three changes are negative, tempering the positive evidence from the faster hourly averages.

Reported 24-hour volume is 3,751,745, and volume is 0.45% of market capitalization. Without comparative volume data, these figures do not establish whether participation is rising or falling, so they offer limited confirmation of either the short-term bounce or the broader weakness.

The current price is roughly 79.5% below the stated all-time high of $4.07 from May 12, 2021. That indicates a substantial historical decline, but the high alone does not establish current support, resistance, or a likely recovery path.

Overall, the rating is Hold: the price’s position above its three fastest hourly averages and within the upper part of the daily range are constructive, but they are offset by trading below the 55- and 144-hour averages and negative returns over each reported performance window. The primary evidence supporting Hold is this balance between modest near-term strength and unresolved broader weakness, with RSI readings offering no decisive confirmation.